Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) (343339)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    The goal of this Funding Opportunity Announcement (FOA) is to expedite the development of medications for Substance Use Disorders (SUDs). It seeks to fund a variety of preclinical and/or clinical research projects aimed at advancing medications closer to FDA approval. The grant emphasizes funding for high-impact studies that can quickly yield essential results. These U01s are expected to be short-term, funded for up to 3 years with grants as large as $5 million per year, involving cooperative agreements with significant NIDA staff involvement to enable critical medication development studies not feasible with traditional R01 activity codes.

    Eligibility

    Organization's Location
    incididunt fugiat
    Program Location
    tempor amet aute Lorem ullamco non dolor
    Organization Type
    up to 5m

    Submission

    Visit Apply for more information.

    Similar grants

    5 of 5 free pages viewed this month
    Sign up to view this and 11k+ more grant opportunities
    Already have an account?Log in